Hans-Joachim Helms

Hans-Joachim Helms

Auto-generated profile, based on publicly available information

Hans-Joachim Helms

Roche Innovation Center Basel, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Head & Face Medicine
Verified
Journal Article
Open access
PDF file
MKMichael Knösel
Michael Knösel
EKElisabeth Klang
Elisabeth Klang
HHHans-Joachim Helms
Hans-Joachim Helms
DWDirk Wiechmann
Dirk Wiechmann
The occurrence of side-effects of fixed orthodontic therapy, such as white-spot lesions and root resorption, are known to be significantly more frequent with increasing duration of treatment. Multi-bracket treatment should be as short as possible, in order to minimize the risks of collateral damage to teeth. The aim of this non-randomized clinical trial was to compare treatment duration with each of two types of customized lingual orthodontic appliances (Incognito, 3 M-Unitek; WIN, DW LingualSystems), taking into account treatment complexity. The null-hypothesis was that there would be no significant difference in active orthodontic treatment duration between them. Of 402 potentially eligible participants, a population sample of n = 376 subjects (nIncognito = 220; nWIN = 156; m/f 172/204; mean age ± SD 17.3 ± 7.7Y) treated in one orthodontic center (Bad Essen, Germany) with completely customized lingual appliances in upper and lower permanent dental arches was recruited with the inclusion criterion of initiated and completed lingual multi-bracket treatment within the assessment period of April 1st 2010 – Nov 30, 2013, and the exclusion criterion of less than 24 bracketed teeth. We used four-factorial ANOVA to assess the impact of the following factors: initial degree of severity of malocclusion (mild to moderate, S1; severe, S2), appliance type (Incognito; WIN), sex, and age group (<=16; >16 Y) on the duration of lingual multi-bracket treatment. Overall, mean treatment duration was 21.7 (SD 7.2) months, which was significantly shorter for WIN for both sub-groups of treatment complexity (S1: 17.96 mo; S2: 20.49 mo) compared to Incognito (S1: 22.7 mo; S2: 29.79 mo). ANOVA revealed a significant influence of the main effects ‘appliance type’, and ‘severity’, independent of each other. Therefore, the null-hypothesis was rejected. In terms of treatment duration, the WIN appliance performed significantly better than the Incognito appliance. Consequently, subjects treated with the WIN appliance are expected to be exposed to lower risks of the typical side-effects associated with longer multi-bracket treatment durations, such as root resorption and enamel decalcification.

1 September 2021 in International Orthodontics
Verified
Journal Article
Open access
FAFawzi M. M AlQatami
Fawzi M. M AlQatami
OAOns Alouini
Ons Alouini
MKMichael Knösel
Michael Knösel
HHHans-Joachim Helms
Hans-Joachim Helms
RSRainer Schwestka-Polly
Rainer Schwestka-Polly
To assess the outcome quality of subjects treated with a completely customized lingual appliance (CCLA) in a postgraduate university program, using the ABO Objective Grading System (OGS), by testing the null-hypothesis of a significant proportion of post-treatment cases exceeding an adjusted 'exam failure' threshold value of OGS=24. This retrospective single-arm study included 66 consecutively debonded CCLA cases (m/f 19/47; mean age: 25.1±9 years) treated at Hannover Medical School (MHH, Hannover, Germany). The discrepancy index (DI) was assessed on initial plaster casts. The OGS of the cast-radiograph evaluation was scored for both set-up and post-treatment casts, including the seven components of alignment/rotation, marginal ridges, buccolingual inclination, overjet, occlusal contacts, occlusal relationships and interproximal contacts, to parameterize differences between those. DI score distribution (≥20, <20) was 25 (37.9%)/41 (62.1%) subjects. Mean initial DI was 17.3±8.5. Mean set-up OGS was 10.4±4.4 (min-max: 3-21), mean final OGS was 17.7±5.9 (min-max: 7-33), and the difference 7.3 (post-treatment - set-up) was statistically significant (p<0.0001; 95% CI [5.8, 8.7]). The null-hypothesis was rejected: A statistically significant proportion of the final casts (n=58; 87.8%) scored below OGS=24 by exact binomial test (P<0.0001; 95% CI [77.5%, 94.6%]). The rate of a final OGS score<24 was not significantly different (P=0.98) between both DI (≥20, <20) groups. The outcome quality of the CCLA treatment in this postgraduate university setting was high and therefore sufficient for a vast majority of treated cases to pass the ABO-OGS clinical examination.

9 September 2015 in Head & Face Medicine
Verified
Journal Article
Open access
PDF file
DWDirk Wiechmann
Dirk Wiechmann
JVJulius Vu
Julius Vu
RSRainer Schwestka-Polly
Rainer Schwestka-Polly
HHHans-Joachim Helms
Hans-Joachim Helms
MKMichael Knösel
Michael Knösel
To assess the types and frequencies of clinical complications experienced when using a modified lingual Herbst appliance and to compare these with those associated with conventional Herbst appliances reported in the literature. Treatment records for 35 consecutive subjects treated during the observation period from October 2013 to August 2014 who received a combination of a lingual appliance and a modified Herbst appliance (WIN, DW LingualSystems) were assessed for complications linked to Herbst treatment phase. Complications were analyzed descriptively, and complication-free intervals were calculated using Kaplan-Meier plots. To enable a comparison with data reported in the literature, the cumulative treatment time for all subjects was divided by the total number of complications. 71.4 % of Herbst treatments were free from complications (n = 25). Complications were seen on 13 occasions (8 instances of Herbst attachment loosening, 5 L-Pin fractures). Most of these complications could be fixed chair side utilizing simple clinical measures. Considering all complications as identical statistical events, the percentage of treatments free from complications would be 88 % for 100 days, 70 % for 200 days and 56.8 % for 300 days. For severe complications, the averaged complication-free treatment interval was found to be 27.8 months. In terms of clinical sturdiness, and taking into consideration the step-wise mode of activation used here as well as the differences in the design of the various Herbst appliances, the WIN-Herbst appliance was found to be superior to comparable vestibular Herbst appliances, as well as the banded Herbst appliance belonging to the preceding generation of customized lingual systems. Success in treatment of non-compliant Angle Class II correction is considered to have better predictability using the modified anchorage strategy of the WIN-Herbst appliance.

1 January 2019 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
TKTheresa Maria Kolben
Theresa Maria Kolben
LELea T Etzel
Lea T Etzel
FBFlorian Bergauer
Florian Bergauer
IHIngke Hagemann
Ingke Hagemann
PHPeter Hillemanns
Peter Hillemanns
CDChristian Dannecker
Christian Dannecker
Kolben TM, et al. J Gynecol Oncol. 2018 Aug;30:e42. https://doi.org/10.3802/jgo.2019.30.e42

11 June 2014 in Journal of Biopharmaceutical Statistics
Verified
Journal Article
Open access
HHH.-J. Helms
H.-J. Helms
NBN. Benda
N. Benda
TFTim Friede
Tim Friede
In a clinical dose finding study with active control a new drug with several dose levels is compared with an active comparator drug. The main focus of such studies often lies on the estimation of a target dose that leads to the same efficacy as the control. This article investigates the finite sample properties of the maximum likelihood estimation of the target dose and compares several approaches for constructing corresponding confidence intervals under the assumption of a linear dose-response curve and normal error terms. Furthermore, the impact of deviations from the model assumptions regarding the error distribution is explored.

22 April 2020 in Head & Face Medicine
Verified
Journal Article
Open access
PDF file
DWDirk Wiechmann
Dirk Wiechmann
HBHans-Peter Bantleon
Hans-Peter Bantleon
BMBirte Melsen
Birte Melsen
BZBjörn Zachrisson
Björn Zachrisson
UHUrban Hägg
Urban Hägg
RSRainer Schwestka-Polly
Rainer Schwestka-Polly
To reproduce the methods and results of the study by Alobeid et al. (2018) in which the efficacy of tooth alignment using conventional labial and lingual orthodontic bracket systems was assessed. We used the identical experimental protocol and tested (i) regular twin bracket (GAC-Twin [Dentsply]) and lingual twin bracket systems (Incognito [3M]), (ii) together with NiTi 0.014” wires (RMO), and (iii) a simulated malocclusion with a displaced maxillary central incisor in the x-axis (2 mm gingivally) and in the z-axis (2 mm labially). The method described by Alobeid et al. (2018) is not reproducible, and cannot be used to assess the efficacy of tooth alignment in labial or lingual orthodontic treatment. Major flaws concern the anteroposterior return of the Thermaloy-NiTi wire ligated with stainless steel ligatures. The reproduced experimental setting showed that a deflected Thermaloy-NiTi wire DOES NOT move back at all to its initial stage (= 0 per cent correction) because of friction and binding (see supplemented video), neither with the tested labial nor with the lingual brackets. Furthermore, an overcorrection of up to 138 per cent, which the authors indicate for some labial bracket-wire combinations and which deserves the characterization “irreal”, stresses the inappropriateness of the method of measurement.Further flaws include: a) incorrect interpretation of the measurement results, where a tooth tripping around (overcorrection) is interpreted as a better outcome than a perfect 100 per cent correction; b) using a statistical test in an inappropriate and misleading way; c) uncritical copying of text passages from older publications to describe the method, which do not correspond to this experimental protocol and lead to calculation errors; d) wrong citations; e)differences in table and bar graph values of the same variable; f) using a lingual mushroom shaped 0.013” Thermaloy-NiTi wire which does not exist; g) drawing uncritical conclusions of so called "clinical relevance" from a very limited in vitro testing. Clinical recommendations based on in vitro measurements using the Orthodontic Measurement and Simulation System (OMSS) should be read with caution.